Janssen Pharmaceuticals has signed a licensing deal with Depomed for its Acuform gastric retentive drug delivery technology. As per the agreement, Janssen gained non-exclusive license and other rights to certain Acuform patents and in ...
Tags: Janssen Pharmaceuticals, Acuform Patents, drug delivery technology
West Pharmaceutical Services has announced an agreement with Janssen Biotech, a biotechnology company to partner on the development and manufacturing of a new self-injection product developed by Janssen. The new injection technology, ...
Janssen Research and Development has received the Priority Review for the supplemental New Drug Application (sNDA) for ZYTIGA from US Food and Drug Administration (FDA). Zytiga (abiraterone acetate) is administered in combination with ...
Tags: sNDA, priority review, FDA
At the 13th Annual Symposium on the Science and Technology of Lighting,top-level technologists from LED and lighting companies presented their thoughts on the future of lighting with a heavy emphasis on SSL. The Lighting Research ...
Janssen Research & Development has announced that it has submitted a supplemental New Drug Application to FDA for ZYTIGA(abiraterone acetate). Janssen-Cilag International NV has also sent a type II variation to the European Medicines ...